PSI-6206 (GS-331007)

1 1

Selleck Chemicals

S5307-25MG

€144,00 EUR
€144,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

PSI-6206 (GS-331007) is an inhibitor of HCV Protease used in studies of Viral Entry / Replication. It is especially relevant in infectious disease models, where defined compound exposure can be linked to host-pathogen interactions, entry mechanisms, and replication-associated responses.

By inhibiting HCV Protease, PSI-6206 (GS-331007) can be used to examine host-pathogen interactions, entry mechanisms, and replication-associated responses. The protease annotation adds relevance to protease-activity, cleavage, and substrate-processing assays, together with downstream-response mapping in the same experimental setting. In infectious disease models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving HCV Protease
  • Pathway perturbation studies connected to Viral Entry / Replication
  • Concentration-response inhibition and target-dependence studies
  • Protease-activity, cleavage, and substrate-processing assays

Overall, PSI-6206 (GS-331007) is appropriate when a defined chemical perturbant is needed to connect HCV Protease with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in infectious disease models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
HCV Protease
Target Class:
Protease
Pathways:
Viral Entry / Replication
Research Area:
Infectious Disease
CAS No.:
863329-66-2
Molecular Weight:
260.22
Formula:
C₁₀H₁₃FN₂O₅
SMILES:
CC1(C(C(OC1N2C=CC(=O)NC2=O)CO)O)F
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.